Determination of Low IgG Class Antibody Avidity Percentage by IgM Levels Specific to Toxoplasma Gondii
- PMID: 35975508
- DOI: 10.7754/Clin.Lab.2021.211112
Determination of Low IgG Class Antibody Avidity Percentage by IgM Levels Specific to Toxoplasma Gondii
Abstract
Background: Ig (Immunglobulin) M detection and low avidity index are markers of recent infection in differentiating acute and chronic stages of Toxoplasma gondii (T. gondii) infections. In this study, we aimed to evaluate whether the anti-T. gondii IgM antibody index threshold value could be a predictive factor in the estimation of low avidity and its use in improving the diagnosis of early toxoplasma infection.
Methods: Anti-T. gondii IgM, IgG antibody and IgG avidity results were analyzed. Anti-T. gondii IgG and IgM antibodies in blood samples were studied with chemiluminescent microparticle immunoassay (CMIA), and IgG avidity test was performed with Enzyme Linked Fluorescent Assay (ELFA) technique.
Results: The overall seroprevalence of anti-T. gondii antibodies (IgG and/or IgM) was 19.4%. Of the 64 patients whose avidity tests were studied, 47 (73.4%) were female. Twenty seven (57.4%) of the women were pregnant. In the IgG avidity test, 7.8% low avidity was detected. Low avidity was detected in only 4 (15.4%) of 26 IgM positive cases. IgM analysis of a case (6-month-old baby) with low avidity was found to be negative. In the prediction of low avidity, the assay's IgM positivity cutoff value was ≥ 0.6, its sensitivity, specificity, positive predictive value, and negative predictive value were 80%, 62.7%, 2.3%, and 99.7%, respectively. With Architect, 37.3% of samples were false positive. Determining the IgM index cutoff value was unsuccessful in distinguishing low avidity. The area under the ROC curve was 0.574 (p = 0.60).
Conclusions: In our study, the positive predictive value of the IgM test kit in estimating low avidity was low and the false positivity rate was 37.3%. It is thought that the index cutoff value of the anti-T. gondii IgM antibody test kit cannot be considered as a good predictor of recent infection. Studies with larger patient groups are needed.
Similar articles
-
Comparison of the efficiency of two commercial kits - ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women.Ann Agric Environ Med. 2016 Dec 23;23(4):570-575. doi: 10.5604/12321966.1226848. Ann Agric Environ Med. 2016. PMID: 28030925
-
[Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm].Mikrobiyol Bul. 2014 Apr;48(2):283-91. doi: 10.5578/mb.7000. Mikrobiyol Bul. 2014. PMID: 24819265 Turkish.
-
Toxoplasma gondii IgG avidity for the diagnosis of primary infection in pregnant women: Comparison between chemiluminescent microparticle immunoassay and enzyme-linked immunosorbent assay.J Infect Chemother. 2024 May;30(5):434-438. doi: 10.1016/j.jiac.2023.11.019. Epub 2023 Nov 23. J Infect Chemother. 2024. PMID: 38000499
-
Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy.J Clin Microbiol. 2020 Aug 24;58(9):e00505-20. doi: 10.1128/JCM.00505-20. Print 2020 Aug 24. J Clin Microbiol. 2020. PMID: 32321784 Free PMC article. Review.
-
Assessment of simultaneous IgM, IgG avidity, and IgA testing in diagnosis of acute toxoplasmosis in pregnant women: a systematic review and meta-analysis study.BMC Pregnancy Childbirth. 2025 May 6;25(1):537. doi: 10.1186/s12884-025-07580-6. BMC Pregnancy Childbirth. 2025. PMID: 40329230 Free PMC article.
Cited by
-
Evaluation of different cut-off points for IgG avidity and IgM in the diagnosis of acute toxoplasmosis in pregnant women participating in a congenital toxoplasmosis screening program.Rev Inst Med Trop Sao Paulo. 2024 Jul 29;66:e43. doi: 10.1590/S1678-9946202466043. eCollection 2024. Rev Inst Med Trop Sao Paulo. 2024. PMID: 39082482 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical